OpenLegislation

Introductory text

United Kingdom

Original text. Later amendments are not shown.

Commission Implementing Decision

of 26 April 2011

allowing Member States to extend provisional authorisations granted for the new active substances ascorbic acid, ipconazole, spiromesifen, topramezone, and Pseudomonas sp. strain DSMZ 13134

(notified under document C(2011) 2668)

(Text with EEA relevance)

(2011/252/EU) (revoked)

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations

Textual amendments

F1

Decision revoked (31.12.2020) by The Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019 (S.I. 2019/556), reg. 1(1), Sch. 2 Pt. 2 (with reg. 29(2)) (as amended by S.I. 2020/1376, regs. 1(4), 3(20)); 2020 c. 1, Sch. 5 para. 1(1)